Publications
Publication List
The following is a list of some of the many medical journals and articles authored by or featuring our team here at Peninsula Research Associates.
- Prevalence of Comorbidities with Peanut Allergy: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) The Journal of Allergy and Clinical Immunology February 2019.
- A Randomized Phase 3 Study, Sinus-52, Evaluating the Efficacy and Safety of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps The Journal of Allergy and Clinical Immunology, February 2019.
- AR101 Oral Immunotherapy for Peanut Allergy The New England Journal of Medicine, 22 November 2018.
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma The New England Journal of Medicine 28 June 2018.
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma The New England Journal of Medicine, 28 June 2018.
- Treatment of Asthmatic Patients with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Compared with Placebo: Patient-Reported Outcomes and Quality of Life The Journal of Allergy and Clinical Immunology, February 2017.
- Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis The Journal of Allergy and Clinical Immunology, February 2017.
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels The New England Journal of Medicine, 27 June 2013.
- Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma The Journal of Allergy and Clinical Immunology, February 2014.
- Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
Alissa is a board-certified family nurse practitioner with extensive experience in clinical research across pediatric, adolescent, and adult populations. As an Investigator at PRA, she leverages her expertise to support diverse areas of clinical trials to support advancements in healthcare.
Paige began working as a clinical research coordinator at Peninsula Research Associates in 2020. Since joining our team, she has worked on various clinical trials, including COVID-19 antibody treatment studies, a phase II recombinant protein COVID-19 vaccine study, a phase I mRNA COVID-19 vaccine study and a phase III pneumococcal vaccine study. Paige is passionate about helping patients receive quality healthcare through clinical research.
Kristen joined the PRA team as a clinical research coordinator in 2018. She primarily works with Oral Immunotherapy (OIT) food allergy trials, including peanut and egg allergy studies. Her study on Palforzia just got approved by the FDA! She will soon be leading a study involving OIT multi-food allergies. Additionally, Kristen’s areas of research include asthma, atopic dermatitis, COVID-19 vaccines, COVID-19 antibody treatments, and pneumococcal vaccines.
Heather has been working as a clinical research coordinator at Peninsula Research Associates since 2017. She currently devotes her time to PRA’s phase III trials, focusing primarily on asthma, atopic dermatitis and diabetes studies. Heather helps maintain a high level of patient care while ensuring our research goals are being met.
Monika manages the research coordinators and research assistants at Peninsula Research Associates. She also currently works on PRA’s trials in the following areas; COVID-19 and non-COVID-19 Vaccines, COVID-19 Monoclonal Antibodies, Quality of Life/Exercise Capacity asthma, atopic dermatitis and eosinophilic esophagitis. She helps the PRA team maintain a high level of patient care while ensuring our research goals are being met.
Debbie Cappy began working with Dr. Sher in 1991 and has played a key role in over 300 clinical research trials. Debbie’s areas of expertise include allergic rhinitis, asthma, attention-deficit/hyperactivity disorder, autism, chronic obstructive pulmonary disease, diabetes, hypercholesterolemia, infectious diseases, otitis media, pain management, sleep disorders, vaccinations, women’s health, and, most recently, COVID-19 vaccinations and treatments.
As Chief Financial Officer, Renée manages all cost, managerial, and financial accounting for Peninsula Research Associates. She is responsible for the day-to-day administration of accounts receivable, accounts payable, payroll, benefits, and human resources. In addition to assisting management with important financial decisions, Renée also prepares forecasts, budgets, and financial statements. Renée’s expertise includes determining ways to reduce costs and meeting the legal requirements to keep the financial state of Peninsula Research Associates in good standing.
Leigh Ann is a board licensed family nurse practitioner. She serves as a research sub-investigator for many of our studies at Peninsula Research Associates. Her primary focus is on food allergy treatments, eczema, asthma and COVID-19 vaccines and treatments.
Dr. Sher completed his medical degree at the University of Utah School of Medicine (1983) and residency in pediatrics (1987) and fellowship in allergy and immunology at the University of California Los Angeles.